This core facility is also a member of the National Network of Advanced Proteomics Infrastructure (NAPI), which is funded by the Research Council of Norway INFRASTRUKTUR-program (project number: 295910)
Sanofi Industry Developments July 2026: Novo Nordisk received CDSCO approval for Wegovy (semaglutide) as the first and only GLP-1 receptor agonist approved in India for noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) with moderate to advanced liver fibrosis, expanding the drug's indication beyond weight management and type 2 diabetes
I do a three-layer closure so that the most superficial layer of skin is perfectly aligned and touching, says Dr
Focus on compound movements like squats, deadlifts, push-ups, and rows
In contrast, injections avoid these barriers entirely
Side effects such as upper respiratory infection, low white blood cell count, and suicidality necessitate more extensive trials to confirm safety (Papp 2012